Understanding the Potential of Emerging Technologies to Identify Target ADC Patients

  • Exploring applications of liquid biopsies and ctDNA in the development and characterization of ADCs
  • Understanding how liquid biopsies can be used in early clinical development, such as informing dose selection
  • Applying lessons learned to ongoing and future ADCs